Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
U.S. News & World Report
|
November 8, 1993
Send in the clones
Shannon Brownlee
AHIP Coverage
|
June 18, 2005
Putting consumers in the driver's seat?
Shannon Brownlee
Medscape Journal of Medicine
|
December 23, 2008
Doing better for less: the case for organized group practices
Shannon Brownlee
U.S. News & World Report
|
August 14, 1995
The king of the apes
Shannon Brownlee
Time
|
February 9, 2002
Staying healthy. Too heavy, too young
Shannon Brownlee
BMJ (Clinical Research Ed.)
|
November 21, 2025
Will the new FDA fix the old FDA?
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
September 16, 2021
Should regulatory authorities approve drugs based on surrogate endpoints?
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
July 2, 2015
Diverting attention from financial conflicts of interest
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
September 25, 2024
Donanemab: Conflicts of interest found in FDA committee that approved new Alzheimer's drug
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
October 12, 2011
US expert panel recommends against prostate cancer screening
Jeanne Lenzer, Shannon Brownlee
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
U.S. News & World Report
|
November 8, 1993
Send in the clones
Shannon Brownlee
AHIP Coverage
|
June 18, 2005
Putting consumers in the driver's seat?
Shannon Brownlee
Medscape Journal of Medicine
|
December 23, 2008
Doing better for less: the case for organized group practices
Shannon Brownlee
U.S. News & World Report
|
August 14, 1995
The king of the apes
Shannon Brownlee
Time
|
February 9, 2002
Staying healthy. Too heavy, too young
Shannon Brownlee
BMJ (Clinical Research Ed.)
|
November 21, 2025
Will the new FDA fix the old FDA?
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
September 16, 2021
Should regulatory authorities approve drugs based on surrogate endpoints?
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
July 2, 2015
Diverting attention from financial conflicts of interest
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
September 25, 2024
Donanemab: Conflicts of interest found in FDA committee that approved new Alzheimer's drug
Jeanne Lenzer, Shannon Brownlee
BMJ (Clinical Research Ed.)
|
October 12, 2011
US expert panel recommends against prostate cancer screening
Jeanne Lenzer, Shannon Brownlee
Page
of 4